These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2311679)

  • 1. Ibuprofen, a putative anti-cataract drug, protects the lens against cyanate and galactose.
    Roberts KA; Harding JJ
    Exp Eye Res; 1990 Feb; 50(2):157-64. PubMed ID: 2311679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspirin prevents carbamylation of soluble lens proteins and prevents cyanate-induced phase separation opacities in vitro: a possible mechanism by which aspirin could prevent cataract.
    Crompton M; Rixon KC; Harding JJ
    Exp Eye Res; 1985 Feb; 40(2):297-311. PubMed ID: 3979467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bendazac prevents cyanate binding to soluble lens proteins and cyanate-induced phase-separation opacities in vitro: a possible mechanism by which bendazac could delay cataract.
    Lewis BS; Rixon KC; Harding JJ
    Exp Eye Res; 1986 Dec; 43(6):973-9. PubMed ID: 3817034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reaction of aspirin with cysteinyl residues of lens gamma-crystallins: a mechanism for the proposed anti-cataract effect of aspirin.
    Qin W; Smith JB; Smith DL
    Biochim Biophys Acta; 1993 Apr; 1181(2):103-10. PubMed ID: 8481398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of aminoguanidine on the glycation (non-enzymic glycosylation) of lens proteins.
    Lewis BS; Harding JJ
    Exp Eye Res; 1990 May; 50(5):463-7. PubMed ID: 2373149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The non-enzymic glycosylation of bovine lens proteins by glucosamine and its inhibition by aspirin, ibuprofen and glutathione.
    Ajiboye R; Harding JJ
    Exp Eye Res; 1989 Jul; 49(1):31-41. PubMed ID: 2759189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigations of ibuprofen and paracetamol binding to lens proteins to explore their protective role against cataract.
    Shyadehi AZ; Harding JJ
    Biochem Pharmacol; 1991 Nov; 42(11):2077-84. PubMed ID: 1958225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of cataract in diabetic rats by aspirin, paracetamol (acetaminophen) and ibuprofen.
    Blakytny R; Harding JJ
    Exp Eye Res; 1992 Apr; 54(4):509-18. PubMed ID: 1623937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspirin prevents the nonenzymatic glycosylation and carbamylation of the human eye lens crystallins in vitro.
    Rao GN; Cotlier E
    Biochem Biophys Res Commun; 1988 Mar; 151(3):991-6. PubMed ID: 3355566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High galactose levels in vitro and in vivo impair ascorbate regeneration and increase ascorbate-mediated glycation in cultured rat lens.
    Saxena P; Saxena AK; Monnier VM
    Exp Eye Res; 1996 Nov; 63(5):535-45. PubMed ID: 8994357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-enzymic glycosylation (glycation) of lens proteins by galactose and protection by aspirin and reduced glutathione.
    Huby R; Harding JJ
    Exp Eye Res; 1988 Jul; 47(1):53-9. PubMed ID: 3409987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effects of ibuprofen and its major metabolites against in vitro inactivation of catalase and fumarase: relevance to cataract.
    Shyadehi AZ; Harding JJ
    Biochim Biophys Acta; 2002 May; 1587(1):31-5. PubMed ID: 12009421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acetylation of lens crystallins: a possible mechanism by which aspirin could prevent cataract formation.
    Rao GN; Lardis MP; Cotlier E
    Biochem Biophys Res Commun; 1985 May; 128(3):1125-32. PubMed ID: 4004853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of magnesium taurate on the onset and progression of galactose-induced experimental cataract: in vivo and in vitro evaluation.
    Agarwal R; Iezhitsa I; Awaludin NA; Ahmad Fisol NF; Bakar NS; Agarwal P; Abdul Rahman TH; Spasov A; Ozerov A; Mohamed Ahmed Salama MS; Mohd Ismail N
    Exp Eye Res; 2013 May; 110():35-43. PubMed ID: 23428743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The major metabolite of bendazac inhibits the glycosylation of soluble lens proteins: a possible mechanism for a delay in cataractogenesis.
    Lewis BS; Harding JJ
    Exp Eye Res; 1988 Aug; 47(2):217-25. PubMed ID: 3409993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ibuprofen protects alpha-crystallin against posttranslational modification by preventing protein cross-linking.
    Plater ML; Goode D; Crabbe MJ
    Ophthalmic Res; 1997; 29(6):421-8. PubMed ID: 9380344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of 6-phosphogluconate dehydrogenase by carbamylation and protection by alpha-crystallin, a chaperone-like protein.
    Ganea E; Harding JJ
    Biochem Biophys Res Commun; 1996 May; 222(2):626-31. PubMed ID: 8670255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Taurine prevents galactose-induced cataracts.
    Malone JI; Benford SA; Malone J
    J Diabetes Complications; 1993; 7(1):44-8. PubMed ID: 8481550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New regulatory protein isolated from the bovine eye lens and its action on the cataract development in rat in vitro].
    Krasnov MS; Gurmizov EP; Iamskova VP; Gundorova RA; Iamskov IA
    Vestn Oftalmol; 2005; 121(1):37-9. PubMed ID: 15759848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of galactose-induced alterations in ocular lens with sorbinil.
    Unakar NJ; Tsui JY
    Exp Eye Res; 1983 May; 36(5):685-94. PubMed ID: 6303825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.